Leinamycin E1 acting as an anticancer prodrug activated by reactive oxygen speciesSheng‐Xiong Huang, Ben Shen, Dawn R. Church et al.|Proceedings of the National Academy of Sciences|2015Cited by 51
Abstract 2899: Mitophagy imparts enzalutamide resistance in prostate cancerHirak S. Basu, George Wilding, Cynthia L. Schrieber et al.|Cancer Research|2015Cited by 1